Loading…
Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability
Antibiotics become less effective in treating infectious diseases as resistance increases. S taphylococcus aureus is a global problem due to its ability to form biofilms and resistance mechanisms. Phage endolysin is one of the most promising methods for combating antibiotic resistance. ZAM-MSC chime...
Saved in:
Published in: | AMB Express 2024-12, Vol.14 (1), p.143-12, Article 143 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c3482-817950b4a62bae6bee1ffcd2e1325d4fa34505e309445cbed33d584431cedecd3 |
container_end_page | 12 |
container_issue | 1 |
container_start_page | 143 |
container_title | AMB Express |
container_volume | 14 |
creator | Momen, Sanaz Soleimani, Neda Azizmohseni, Farzaneh Ahmadbeigi, Yasaman Borhani, Seddigheh Amini-Bayat, Zahra |
description | Antibiotics become less effective in treating infectious diseases as resistance increases. S
taphylococcus aureus
is a global problem due to its ability to form biofilms and resistance mechanisms. Phage endolysin is one of the most promising methods for combating antibiotic resistance. ZAM-MSC chimeric endolysin has three domains derived from SAL1 and lysostaphin, which target the peptide bridge of peptidoglycan. In this study purified ZAM-MSC (with yield of 30 mg/lit) had bactericidal activity against methicillin-sensitive
Staphylococcus aureus
(MSSA) and methicillin-resistant
Staphylococcus aureus
(MRSA) at low concentrations (2.38 μg/ml and 1.88 μg/ml, respectively). The antibacterial spectrum revealed that ZAM-MSC was active against diverse
Staphylococci
. it has maintained 100% stability after 24 h incubation in pH 5 to 10 against
S. aureus
, as well as demonstrated significant thermostability and maintained nearly its full activity at different temperatures (4–42 °C) up to 1 day of incubation. The anti-biofilm activity of various concentrations of ZAM-MSC against MSSA and MRSA biofilms was not dose-dependent, and antibiofilm activity was observed even at low concentrations (14 μg/ml). Further, the molecular dynamics simulations demonstrated that the ZAM-MSC chimer and its parent proteins remained dynamically stable, showing similar flexibility despite the size and hydrogen bond number differences. In conclusion, the study reveals that chimeric ZAM-MSC is a distinctive enzyme with exceptional biochemical properties and rapid lytic activity against
Staphylococci
. |
doi_str_mv | 10.1186/s13568-024-01812-2 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_798f6c85027a49c3a5fcb696e23fb921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_798f6c85027a49c3a5fcb696e23fb921</doaj_id><sourcerecordid>3149542010</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3482-817950b4a62bae6bee1ffcd2e1325d4fa34505e309445cbed33d584431cedecd3</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhSMEolXpH2CBLLFhE_A78bIaUahUhMRjbd3Y1zMeJXGxM6qGX4_blIJY4I2te79zfO3TNC8ZfctYr98VJpTuW8plS1nPeMufNKecGdbSXqmnf51PmvNS9rQuRanR6nlzIkzHpRD6tImbHWRwC-b4E5aYZgKzJ0NMcQ4pT7XkagXGY4mFpECAzHhL3C5OVeEIzj7d9apsC3EuC_n05esFuY3LjmwzwkLKAkMc43J80TwLMBY8f9jPmu-X779tPrbXnz9cbS6uWydkz9uedUbRQYLmA6AeEFkIznNkgisvAwipqEJBjZTKDeiF8KqXUjCHHp0XZ83V6usT7O1NjhPko00Q7X0h5a2FXJ81ou1MH7TrFeUdSOMEqOAGbTRyEQbDWfV6s3rd5PTjgGWxUywOxxFmTIdiBZNGSU4Zrejrf9B9OuT6cyslRB2_qxRfKZdTKRnD44CM2rtc7Zqrrbna-1wtr6JXD9aHYUL_KPmdYgXECpTamreY_9z9H9tfP1-teg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3149333257</pqid></control><display><type>article</type><title>Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><source>Free Full-Text Journals in Chemistry</source><creator>Momen, Sanaz ; Soleimani, Neda ; Azizmohseni, Farzaneh ; Ahmadbeigi, Yasaman ; Borhani, Seddigheh ; Amini-Bayat, Zahra</creator><creatorcontrib>Momen, Sanaz ; Soleimani, Neda ; Azizmohseni, Farzaneh ; Ahmadbeigi, Yasaman ; Borhani, Seddigheh ; Amini-Bayat, Zahra</creatorcontrib><description>Antibiotics become less effective in treating infectious diseases as resistance increases. S
taphylococcus aureus
is a global problem due to its ability to form biofilms and resistance mechanisms. Phage endolysin is one of the most promising methods for combating antibiotic resistance. ZAM-MSC chimeric endolysin has three domains derived from SAL1 and lysostaphin, which target the peptide bridge of peptidoglycan. In this study purified ZAM-MSC (with yield of 30 mg/lit) had bactericidal activity against methicillin-sensitive
Staphylococcus aureus
(MSSA) and methicillin-resistant
Staphylococcus aureus
(MRSA) at low concentrations (2.38 μg/ml and 1.88 μg/ml, respectively). The antibacterial spectrum revealed that ZAM-MSC was active against diverse
Staphylococci
. it has maintained 100% stability after 24 h incubation in pH 5 to 10 against
S. aureus
, as well as demonstrated significant thermostability and maintained nearly its full activity at different temperatures (4–42 °C) up to 1 day of incubation. The anti-biofilm activity of various concentrations of ZAM-MSC against MSSA and MRSA biofilms was not dose-dependent, and antibiofilm activity was observed even at low concentrations (14 μg/ml). Further, the molecular dynamics simulations demonstrated that the ZAM-MSC chimer and its parent proteins remained dynamically stable, showing similar flexibility despite the size and hydrogen bond number differences. In conclusion, the study reveals that chimeric ZAM-MSC is a distinctive enzyme with exceptional biochemical properties and rapid lytic activity against
Staphylococci
.</description><identifier>ISSN: 2191-0855</identifier><identifier>EISSN: 2191-0855</identifier><identifier>DOI: 10.1186/s13568-024-01812-2</identifier><identifier>PMID: 39724336</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Antibiotic resistance ; Antibiotics ; Bactericidal activity ; Biofilm ; Biofilms ; Biomedical and Life Sciences ; Biotechnology ; Bond number ; Chemical bonds ; Chimeric endolysin ; Drug resistance ; Dynamic stability ; Hydrogen bonds ; Infectious diseases ; Life Sciences ; Low concentrations ; Lysostaphin ; Methicillin ; Microbial Genetics and Genomics ; Microbiology ; Molecular dynamics ; MRSA ; Original Article ; Peptidoglycans ; Staphylococcus aureus ; Staphylococcus infections ; Thermal stability</subject><ispartof>AMB Express, 2024-12, Vol.14 (1), p.143-12, Article 143</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>Copyright Springer Nature B.V. Dec 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3482-817950b4a62bae6bee1ffcd2e1325d4fa34505e309445cbed33d584431cedecd3</cites><orcidid>0000-0003-2667-0486</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3149333257/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3149333257?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25752,27923,27924,37011,37012,44589,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39724336$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Momen, Sanaz</creatorcontrib><creatorcontrib>Soleimani, Neda</creatorcontrib><creatorcontrib>Azizmohseni, Farzaneh</creatorcontrib><creatorcontrib>Ahmadbeigi, Yasaman</creatorcontrib><creatorcontrib>Borhani, Seddigheh</creatorcontrib><creatorcontrib>Amini-Bayat, Zahra</creatorcontrib><title>Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability</title><title>AMB Express</title><addtitle>AMB Expr</addtitle><addtitle>AMB Express</addtitle><description>Antibiotics become less effective in treating infectious diseases as resistance increases. S
taphylococcus aureus
is a global problem due to its ability to form biofilms and resistance mechanisms. Phage endolysin is one of the most promising methods for combating antibiotic resistance. ZAM-MSC chimeric endolysin has three domains derived from SAL1 and lysostaphin, which target the peptide bridge of peptidoglycan. In this study purified ZAM-MSC (with yield of 30 mg/lit) had bactericidal activity against methicillin-sensitive
Staphylococcus aureus
(MSSA) and methicillin-resistant
Staphylococcus aureus
(MRSA) at low concentrations (2.38 μg/ml and 1.88 μg/ml, respectively). The antibacterial spectrum revealed that ZAM-MSC was active against diverse
Staphylococci
. it has maintained 100% stability after 24 h incubation in pH 5 to 10 against
S. aureus
, as well as demonstrated significant thermostability and maintained nearly its full activity at different temperatures (4–42 °C) up to 1 day of incubation. The anti-biofilm activity of various concentrations of ZAM-MSC against MSSA and MRSA biofilms was not dose-dependent, and antibiofilm activity was observed even at low concentrations (14 μg/ml). Further, the molecular dynamics simulations demonstrated that the ZAM-MSC chimer and its parent proteins remained dynamically stable, showing similar flexibility despite the size and hydrogen bond number differences. In conclusion, the study reveals that chimeric ZAM-MSC is a distinctive enzyme with exceptional biochemical properties and rapid lytic activity against
Staphylococci
.</description><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Bactericidal activity</subject><subject>Biofilm</subject><subject>Biofilms</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnology</subject><subject>Bond number</subject><subject>Chemical bonds</subject><subject>Chimeric endolysin</subject><subject>Drug resistance</subject><subject>Dynamic stability</subject><subject>Hydrogen bonds</subject><subject>Infectious diseases</subject><subject>Life Sciences</subject><subject>Low concentrations</subject><subject>Lysostaphin</subject><subject>Methicillin</subject><subject>Microbial Genetics and Genomics</subject><subject>Microbiology</subject><subject>Molecular dynamics</subject><subject>MRSA</subject><subject>Original Article</subject><subject>Peptidoglycans</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus infections</subject><subject>Thermal stability</subject><issn>2191-0855</issn><issn>2191-0855</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kUtv1DAUhSMEolXpH2CBLLFhE_A78bIaUahUhMRjbd3Y1zMeJXGxM6qGX4_blIJY4I2te79zfO3TNC8ZfctYr98VJpTuW8plS1nPeMufNKecGdbSXqmnf51PmvNS9rQuRanR6nlzIkzHpRD6tImbHWRwC-b4E5aYZgKzJ0NMcQ4pT7XkagXGY4mFpECAzHhL3C5OVeEIzj7d9apsC3EuC_n05esFuY3LjmwzwkLKAkMc43J80TwLMBY8f9jPmu-X779tPrbXnz9cbS6uWydkz9uedUbRQYLmA6AeEFkIznNkgisvAwipqEJBjZTKDeiF8KqXUjCHHp0XZ83V6usT7O1NjhPko00Q7X0h5a2FXJ81ou1MH7TrFeUdSOMEqOAGbTRyEQbDWfV6s3rd5PTjgGWxUywOxxFmTIdiBZNGSU4Zrejrf9B9OuT6cyslRB2_qxRfKZdTKRnD44CM2rtc7Zqrrbna-1wtr6JXD9aHYUL_KPmdYgXECpTamreY_9z9H9tfP1-teg</recordid><startdate>20241226</startdate><enddate>20241226</enddate><creator>Momen, Sanaz</creator><creator>Soleimani, Neda</creator><creator>Azizmohseni, Farzaneh</creator><creator>Ahmadbeigi, Yasaman</creator><creator>Borhani, Seddigheh</creator><creator>Amini-Bayat, Zahra</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><general>SpringerOpen</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>L6V</scope><scope>LK8</scope><scope>M7P</scope><scope>M7S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2667-0486</orcidid></search><sort><creationdate>20241226</creationdate><title>Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability</title><author>Momen, Sanaz ; Soleimani, Neda ; Azizmohseni, Farzaneh ; Ahmadbeigi, Yasaman ; Borhani, Seddigheh ; Amini-Bayat, Zahra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3482-817950b4a62bae6bee1ffcd2e1325d4fa34505e309445cbed33d584431cedecd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Bactericidal activity</topic><topic>Biofilm</topic><topic>Biofilms</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnology</topic><topic>Bond number</topic><topic>Chemical bonds</topic><topic>Chimeric endolysin</topic><topic>Drug resistance</topic><topic>Dynamic stability</topic><topic>Hydrogen bonds</topic><topic>Infectious diseases</topic><topic>Life Sciences</topic><topic>Low concentrations</topic><topic>Lysostaphin</topic><topic>Methicillin</topic><topic>Microbial Genetics and Genomics</topic><topic>Microbiology</topic><topic>Molecular dynamics</topic><topic>MRSA</topic><topic>Original Article</topic><topic>Peptidoglycans</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus infections</topic><topic>Thermal stability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Momen, Sanaz</creatorcontrib><creatorcontrib>Soleimani, Neda</creatorcontrib><creatorcontrib>Azizmohseni, Farzaneh</creatorcontrib><creatorcontrib>Ahmadbeigi, Yasaman</creatorcontrib><creatorcontrib>Borhani, Seddigheh</creatorcontrib><creatorcontrib>Amini-Bayat, Zahra</creatorcontrib><collection>SpringerOpen</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>MEDLINE - Academic</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>AMB Express</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Momen, Sanaz</au><au>Soleimani, Neda</au><au>Azizmohseni, Farzaneh</au><au>Ahmadbeigi, Yasaman</au><au>Borhani, Seddigheh</au><au>Amini-Bayat, Zahra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability</atitle><jtitle>AMB Express</jtitle><stitle>AMB Expr</stitle><addtitle>AMB Express</addtitle><date>2024-12-26</date><risdate>2024</risdate><volume>14</volume><issue>1</issue><spage>143</spage><epage>12</epage><pages>143-12</pages><artnum>143</artnum><issn>2191-0855</issn><eissn>2191-0855</eissn><abstract>Antibiotics become less effective in treating infectious diseases as resistance increases. S
taphylococcus aureus
is a global problem due to its ability to form biofilms and resistance mechanisms. Phage endolysin is one of the most promising methods for combating antibiotic resistance. ZAM-MSC chimeric endolysin has three domains derived from SAL1 and lysostaphin, which target the peptide bridge of peptidoglycan. In this study purified ZAM-MSC (with yield of 30 mg/lit) had bactericidal activity against methicillin-sensitive
Staphylococcus aureus
(MSSA) and methicillin-resistant
Staphylococcus aureus
(MRSA) at low concentrations (2.38 μg/ml and 1.88 μg/ml, respectively). The antibacterial spectrum revealed that ZAM-MSC was active against diverse
Staphylococci
. it has maintained 100% stability after 24 h incubation in pH 5 to 10 against
S. aureus
, as well as demonstrated significant thermostability and maintained nearly its full activity at different temperatures (4–42 °C) up to 1 day of incubation. The anti-biofilm activity of various concentrations of ZAM-MSC against MSSA and MRSA biofilms was not dose-dependent, and antibiofilm activity was observed even at low concentrations (14 μg/ml). Further, the molecular dynamics simulations demonstrated that the ZAM-MSC chimer and its parent proteins remained dynamically stable, showing similar flexibility despite the size and hydrogen bond number differences. In conclusion, the study reveals that chimeric ZAM-MSC is a distinctive enzyme with exceptional biochemical properties and rapid lytic activity against
Staphylococci
.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>39724336</pmid><doi>10.1186/s13568-024-01812-2</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-2667-0486</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2191-0855 |
ispartof | AMB Express, 2024-12, Vol.14 (1), p.143-12, Article 143 |
issn | 2191-0855 2191-0855 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_798f6c85027a49c3a5fcb696e23fb921 |
source | Open Access: PubMed Central; Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access ; Free Full-Text Journals in Chemistry |
subjects | Antibiotic resistance Antibiotics Bactericidal activity Biofilm Biofilms Biomedical and Life Sciences Biotechnology Bond number Chemical bonds Chimeric endolysin Drug resistance Dynamic stability Hydrogen bonds Infectious diseases Life Sciences Low concentrations Lysostaphin Methicillin Microbial Genetics and Genomics Microbiology Molecular dynamics MRSA Original Article Peptidoglycans Staphylococcus aureus Staphylococcus infections Thermal stability |
title | Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T02%3A10%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20and%20bioinformatic%20analysis%20of%20a%20new%20chimeric%20endolysin%20against%20MRSA%20with%20great%20stability&rft.jtitle=AMB%20Express&rft.au=Momen,%20Sanaz&rft.date=2024-12-26&rft.volume=14&rft.issue=1&rft.spage=143&rft.epage=12&rft.pages=143-12&rft.artnum=143&rft.issn=2191-0855&rft.eissn=2191-0855&rft_id=info:doi/10.1186/s13568-024-01812-2&rft_dat=%3Cproquest_doaj_%3E3149542010%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3482-817950b4a62bae6bee1ffcd2e1325d4fa34505e309445cbed33d584431cedecd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3149333257&rft_id=info:pmid/39724336&rfr_iscdi=true |